Inside STAT: Before signing up for a drug trial, she wants to know: Can I afford it?
In “The Medicine Hunters,” a sweeping two-part series, STAT’s Eric Boodman brings to life a strange journey from mountain pasture to clinical trial — “a story,” he says, “about both the wondrous biology behind a potential cancer treatment and the reality of living with a complex illness in America.”
It started, mysteriously, with an epidemic of one-eyed lambs. Ranchers were perplexed, and called in government scientists for help. But what they pinpointed as the culprit wasn’t just a poison; it was also a promising ingredient for cancer drugs. Now, after a 60-year saga, this livestock-scourge-turned- medicine needs one last bit of testing in rare-disease patients. Before volunteering, though, Kaylene Sheran had a question: If the drug works, is there any guarantee that she’ll be able to afford the final product? Read part one of the series here.
It started, mysteriously, with an epidemic of one-eyed lambs. Ranchers were perplexed, and called in government scientists for help. But what they pinpointed as the culprit wasn’t just a poison; it was also a promising ingredient for cancer drugs. Now, after a 60-year saga, this livestock-scourge-turned-
No hay comentarios:
Publicar un comentario